Literature DB >> 8297730

Kaposi's sarcoma in Italy before and after the AIDS epidemic.

M Geddes1, S Franceschi, A Barchielli, F Falcini, S Carli, G Cocconi, E Conti, P Crosignani, L Gafà, L Giarelli.   

Abstract

The incidence of Kaposi's sarcoma (KS) in 1976-90 was assessed in Italy, taking advantage of a network of nine population-based cancer registries covering, at its maximum, approximately 5.6 million subjects. The first examined period (1976-84) substantially reflects the epidemiology of KS prior to the AIDS epidemic in the registration areas. Elevated incidence rates, standardised to the Italian population of 1981, of 1.05/100,000 men and 0.27/100,000 women emerged in 1976-84 (i.e. from two- to threefold higher than in the USA and Sweden, more than tenfold higher than in England and Wales). These high rates, especially remarkable in the Registry from the south of Italy (i.e. Ragusa, 3.01/100,000 men and 0.54/100,000 women) suggest that the prevalence of the still unknown causative agent for KS was high, at least in some parts of Italy, prior to the AIDS epidemic. In the most recent period (1985-90), an approximately twofold increase in KS incidence rates in Italian men below age 50 was observed (from 0.15 in 1976-84 to 0.47 in 1985-90). Conversely, declines in KS incidence were recorded in older men.

Entities:  

Mesh:

Year:  1994        PMID: 8297730      PMCID: PMC1968687          DOI: 10.1038/bjc.1994.60

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome.

Authors:  M Dictor; R Attewell
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

2.  Isolation and identification of a novel virus from patients with AIDS.

Authors:  S C Lo
Journal:  Am J Trop Med Hyg       Date:  1986-07       Impact factor: 2.345

3.  The incidence of second malignancies in subsets of Kaposi's sarcoma.

Authors:  W W Piette
Journal:  J Am Acad Dermatol       Date:  1987-04       Impact factor: 11.527

4.  Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma.

Authors:  G Giraldo; E Beth; E S Huang
Journal:  Int J Cancer       Date:  1980-07-15       Impact factor: 7.396

5.  Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications.

Authors:  B Safai; V Miké; G Giraldo; E Beth; R A Good
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

Review 6.  Secondary neoplasms as a consequence of transplantation and cancer therapy.

Authors:  I Penn
Journal:  Cancer Detect Prev       Date:  1988

7.  Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions.

Authors:  K Rappersberger; E Tschachler; E Zonzits; R Gillitzer; A Hatzakis; A Kaloterakis; D L Mann; T Popow-Kraupp; R J Biggar; R Berger
Journal:  J Invest Dermatol       Date:  1990-10       Impact factor: 8.551

8.  Increased incidence of Kaposi sarcoma in Sweden before the AIDS epidemic.

Authors:  N Bendsöe; M Dictor; J Blomberg; S Agren; K Merk
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

9.  Kaposi's sarcoma in Los Angeles, California.

Authors:  R K Ross; J T Casagrande; R L Dworsky; A Levine; T Mack
Journal:  J Natl Cancer Inst       Date:  1985-12       Impact factor: 13.506

10.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  18 in total

1.  Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women.

Authors:  Andrea Lisco; Massimo Barbierato; Josè R Fiore; Paola Gasperini; Anna Favia; Anna Volpe; Maria Chironna; Giuseppe Pastore; Luigi Chieco-Bianchi; Maria Luisa Calabrò
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

Review 2.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

Review 3.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

4.  Evidence for multiclonality in multicentric Kaposi's sarcoma.

Authors:  P S Gill; Y C Tsai; A P Rao; C H Spruck; T Zheng; W A Harrington; T Cheung; B Nathwani; P A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

5.  Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome.

Authors:  Lena Jakob; Gisela Metzler; Ko-Ming Chen; Claus Garbe
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

6.  High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands.

Authors:  H Hjalgrim; H Tulinius; J Dalberg; S Hardarson; M Frisch; M Melbye
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 7.  Recent insights into the pathogenesis of Kaposi's sarcoma.

Authors:  K Fife; M Bower
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

8.  Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate.

Authors:  H Hjalgrim; M Frisch; M Melbye
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

9.  Classical Kaposi's sarcoma in north-east Sardinia: an overview from 1977 to 1991.

Authors:  F Cottoni; R De Marco; M A Montesu
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

10.  The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic.

Authors:  P Cook-Mozaffari; R Newton; V Beral; D P Burkitt
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.